Bradley L. Campbell, President & CEO at AMICUS THERAPEUTICS, INC. (FOLD), sold 22,900 shares at $11.20 ($257K) on 2023-10-02, disclosed to the SEC on 2023-10-04.
Scheduled sale ($257k) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.20 | 11,200 | $125K | 48.8% |
| 2 | $11.20 | 11,200 | $125K | 48.8% |
| 3 | $12.04 | 500 | $6K | 2.3% |
| Total | $11.22 avg | 22,900 | $257K | 100% |
| Filing → |
| FOLD | SELL | 2025-12-17 | $1.7M | — | Filing → |
| FOLD | SELL | 2025-12-03 | $292K | — | Filing → |
| FOLD | SELL | 2025-11-26 | $293K | — | Filing → |